Master css

Does Testosterone Therapy Confer Risk for Venous Thromboembolism?

In a case-crossover study, testosterone therapy was associated with excess risk.
Testosterone therapy can induce hematologic abnormalities associated with hypercoagulability, but whether it actually confers excess risk for venous thromboembolism (VTE; i.e., deep venous thrombosis or pulmonary embolism) is controversial. In this study, researchers used U.S. national pharmacy and medical claims databases to identify about 40,000 men (mean age, 57) with incident VTE and at least 12 months of data before VTE.

Código de aprobación: PP-MHP-ECU-0002

Todos los derechos reservados © 2019. Pfizer Cía. Ltda. La información contenida en este sitio web tiene exclusivamente propósitos académicos e informativos para profesionales de la salud en la República del Ecuador. Prohibida su reproducción total o parcial sin autorización de su titular.

Para mayor información comuníquese al Departamento Médico de Pfizer. E-mail: [email protected]

PP-GEP-ECU-0071

Master css

Does Testosterone Therapy Confer Risk for Venous Thromboembolism?

{* message_signIn *}

{* message_welcomeBack *}

{* message_welcomeBack *}

{* message_registeringThankYou *}

{* message_emailPasswordResetInstructions *}

Master css

You are here

Educación Médica Relacionada

Does Testosterone Therapy Confer Risk for Venous Thromboembolism?

Únicamente para profesionales de la salud

{* message_withExistingAccount *}

{* message_joinNow *}

{* message_signIn *}

{* message_welcomeBack *}

{* message_welcomeBack *}

{* message_registeringThankYou *}

{* message_emailPasswordResetInstructions *}